Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
FY23 FACILITIES TO FDepartment of Health and Human Services$1.8M obligationsEnds Oct 7, 2025
FY24 FACILITIES TO B - 126598 B560 DRAIN DOWN TANK REPLACEMENTDepartment of Health and Human Services$786.8K obligationsEnds Jan 28, 2026
FY24 FACILITIES TASK ORDER G B376 RENOVATE ROOMS 204-207Department of Health and Human Services$1.1M obligationsEnds Apr 10, 2026
CHARACTERIZING THE MECHANISM OF ACTION (MOA) OF INVESTIGATIONAL/APPROVED CANCER AGENTSDepartment of Health and Human Services$4.6M obligationsEnds Sep 21, 2028
FY22 - APA BUILDINGS - BUILDING 1Department of Health and Human Services$5.7M obligationsEnds Feb 5, 2027
FY22 - APA BUILDINGS - BUILDING 2Department of Health and Human Services$6.2M obligationsEnds Feb 5, 2027
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS (1033).Department of Health and Human Services$6.2M obligationsEnds Feb 5, 2027
THIS IS A CPFF TO TO REFURBISH APA BUILDINGS 1034Department of Health and Human Services$6.3M obligationsEnds Feb 5, 2027
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF…Department of Health and Human Services$89.6M obligationsEnds Jul 31, 2028
PREDICTIVE DRUG TESTING IN ORGANOID MODELSDepartment of Health and Human Services$11.1M obligationsEnds Sep 18, 2029
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERSDepartment of Health and Human Services$56.5M obligationsEnds May 25, 2027
GS-524 PHASE 1 TRIALDepartment of Health and Human Services$4.7M obligationsEnds Jul 6, 2026
IGF::OT::IGF BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTUREDepartment of Health and Human Services$18.5M obligationsEnds Jun 30, 2019
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE…Department of Health and Human Services$97.5M obligationsEnds Sep 24, 2028
FY25 TO-H W3F1 RENOVATIONSDepartment of Health and Human Services$1.9M obligationsEnds May 18, 2027
THE NIAID MISSION AND SCOPE INCLUDING RESEARCH AND DEVELOPMENT OF VACCINES AND THERAPEUTICS FOR THE PREVENTION AND TREATMENT OF DISEASES OF HUMAN CONCERN, INCLUDING MALARIA. THE…Department of Health and Human Services$5.9M obligationsEnds Sep 23, 2030
MEDICINAL CHEMISTRY SUPPORT TO NCATS APP MEDCHEM INITIATIVEDepartment of Health and Human Services$6.3M obligationsEnds Sep 27, 2027
MANUFACTURING OF TPM SUITABLE FOR HUMAN USEDepartment of Health and Human Services$1.5M obligationsEnds Sep 14, 2028
NEOANTIGEN VACCINE CLINICAL TRIALSDepartment of Health and Human Services$4.7M obligationsEnds Sep 24, 2025
IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODY (BNABS) DRUG SUBSTANCE (DS) CLINICAL TRIAL MATERIAL PRODUCTION AND RELEASEDepartment of Health and Human Services$9.2M obligationsEnds Mar 31, 2021
NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)Department of Health and Human Services$6.1M obligationsEnds May 31, 2026
FY24 FACILITIES TO A - 126615 CONVERSION OF ANIMAL ROOMDepartment of Health and Human Services$341.4K obligationsEnds Jan 22, 2026
FY24 FACILITIES TO E - W2F2 CCR AQUATICS FACILITY EXPANSION AND OFFICES ROOMSDepartment of Health and Human Services$1.1M obligationsEnds Feb 27, 2026
PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATIONDepartment of Health and Human Services$10.5M obligationsEnds Aug 31, 2029
IGF::OT::IGF BIOBANKDepartment of Health and Human Services$25.7M obligationsEnds Sep 30, 2025